SCHEMBL22495286

SCHEMBL22495286

N#Cc1ccc(N2CCN(c3ccc(NC(=O)c4ccc(OCC(O)CF)cc4)cc3)CC2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PANK3 Q9H999 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 2/20 0.48
MAPT P10636 10/20 0.47
ALDH1A1 P00352 5/20 0.47
HSD17B10 Q99714 4/20 0.47
ALOX15 P16050 2/20 0.47
HPGD P15428 2/20 0.46
TSHR P16473 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 2/20 0.46
USP2 O75604 2/20 0.45
HIF1A Q16665 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31504187 1.00 PANK3 (0.48) PANK3KMT2AMEN1MAPTALDH1A1
SCHEMBL31504253 0.91 KMT2A (0.54) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL22495263 0.91 KMT2A (0.54) KMT2AMEN1MAPTALDH1A1HSD17B10
SCHEMBL31504191 0.89 KMT2A (0.53) PANK3KMT2AMEN1MAPTALDH1A1
SCHEMBL22495414 0.89 KMT2A (0.53) PANK3KMT2AMEN1MAPTALDH1A1
SCHEMBL22495249 0.88 MAPT (0.54) PANK3KMT2AMEN1MAPTALDH1A1
SCHEMBL31504202 0.88 MAPT (0.54) PANK3KMT2AMEN1MAPTALDH1A1
SCHEMBL22495457 0.85 PANK3 (0.60) PANK3KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL31504200 0.85 PANK3 (0.60) PANK3KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL31504296 0.85 PANK3 (0.48) PANK3KMT2AMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP claimed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US claimed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US claimed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN claimed
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11541132-B2 Radiolabeled compounds SNCA, APP, BACE1 PANK3 4765/4885KMT2A 4463/4885MEN1 311/4885
US-20200316232-A1 RADIOLABELED COMPOUNDS SNCA, APP, BACE1 PANK3 4767/4885KMT2A 4496/4885MEN1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.